ON 102
Alternative Names: ON-102; Radiolabeled anti oxMIF antibody companion diagnostic - OncoOne; Radiolabeled anti‐oxMIF antibody - OncoOneLatest Information Update: 25 Jan 2023
At a glance
- Originator OncoOne
- Class Diagnostic agents; Immunoconjugates; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
- No development reported Inflammation